{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:19:20Z","timestamp":1792264760493,"version":"4.4.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019139","name":"Life Sciences, University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100027043","name":"Milken Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022974","name":"Global Alliance for Chronic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022974","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jad.2025.120335","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T11:25:58Z","timestamp":1758021958000},"page":"120335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PA","title":["Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal"],"prefix":"10.1016","volume":"393","author":[{"given":"Sami George","family":"Sabbah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gia Han","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Badulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hawco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.120335_bb0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jphys.2023.05.012","article-title":"Research note: interpreting findings of a systematic review using GRADE methods","volume":"69","author":"Brennan","year":"2023","journal-title":"J. Physiother."},{"key":"10.1016\/j.jad.2025.120335_bb0010","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/164_2018_107","article-title":"Serotonergic psychedelics: Experimental approaches for assessing mechanisms of action","author":"Canal","year":"2018"},{"key":"10.1016\/j.jad.2025.120335_bb0015","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jad.2025.120335_bb0020","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1073\/pnas.1119598109","article-title":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","volume":"109","author":"Carhart-Harris","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2025.120335_bb0025","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jad.2025.120335_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: FMRI-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2025.120335_bb0035","article-title":"Enhanced independence: De-biasing processes in psychedelic research and beyond","author":"Cheung","year":"2025","journal-title":"Res. Ethics"},{"key":"10.1016\/j.jad.2025.120335_bb0040","doi-asserted-by":"crossref","DOI":"10.1093\/scan\/nsad032","article-title":"The default mode network and rumination in individuals at risk for depression","volume":"18","author":"Chou","year":"2023","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.jad.2025.120335_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2024.02.089","article-title":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity","volume":"353","author":"Copa","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120335_bb0050","unstructured":"Covidence systematic review software., n.d."},{"key":"10.1016\/j.jad.2025.120335_bb0055","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1162\/netn_a_00250","article-title":"Effects of classic psychedelic drugs on turbulent signatures in brain dynamics","volume":"6","author":"Cruzat","year":"2022","journal-title":"Network Neuroscience"},{"key":"10.1016\/j.jad.2025.120335_bb0060","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.jad.2025.120335_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s44220-024-00298-y","article-title":"Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression","volume":"2","author":"Deco","year":"2024","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.jad.2025.120335_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1246892","article-title":"Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-dimethyltryptamine and harmine","volume":"14","author":"Dornbierer","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2025.120335_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01706-y","article-title":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","volume":"11","author":"Doss","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.120335_bb0080","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1021\/acschemneuro.2c00461","article-title":"Skepticism about recent evidence that psilocybin \u201cliberates\u201d depressed minds","volume":"13","author":"Doss","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jad.2025.120335_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.nsa.2024.103938","article-title":"Knowledge gaps in psychedelic medicalisation: clinical studies and regulatory aspects","volume":"3","author":"E-wen McCulloch","year":"2024","journal-title":"Neuroscience Applied"},{"key":"10.1016\/j.jad.2025.120335_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114577","article-title":"The effects of psilocybin in adults with major depressive disorder and the general population: findings from neuroimaging studies","volume":"313","author":"Gill","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.120335_bb0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biopsych.2015.02.020","article-title":"Depressive rumination, the default-mode network, and the dark matter of clinical neuroscience","volume":"78","author":"Hamilton","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.120335_bb0100","article-title":"Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises","author":"Harding","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.120335_bb0105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/02698811231180276","article-title":"Risk of bias in randomized clinical trials on psychedelic medicine: a systematic review","volume":"37","author":"Hovmand","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120335_bb0110","article-title":"Serotonergic psychedelics for depression: what do we know about neurobiological mechanisms of action?","volume":"13","author":"Husain","year":"2023","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.120335_bb0115","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1021\/acsmedchemlett.3c00333","article-title":"Pioneering changes in psychiatry: biomarkers, psychedelics, and AI","volume":"14","author":"Kargbo","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jad.2025.120335_bb0120","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.3174\/ajnr.A3263","article-title":"Resting-state fMRI: a review of methods and clinical applications","volume":"34","author":"Lee","year":"2013","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jad.2025.120335_bb0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40263-021-00877-y","article-title":"Molecular mechanisms of psilocybin and implications for the treatment of depression","volume":"36","author":"Ling","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2025.120335_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26102948","article-title":"The therapeutic potential of psilocybin","volume":"26","author":"Lowe","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jad.2025.120335_bb0135","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.jad.2025.120335_bb0140","first-page":"34","article-title":"Cross-cultural cognitive and affective differences in aging: can culture shape the expression and perception of psychopathology in old age?","volume":"59","author":"Makri","year":"2022","journal-title":"Encephalos"},{"key":"10.1016\/j.jad.2025.120335_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104689","article-title":"Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses","volume":"138","author":"McCulloch","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.120335_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s44271-024-00120-6","article-title":"An integrated theory of false insights and beliefs under psychedelics","volume":"2","author":"McGovern","year":"2024","journal-title":"Communications Psychology"},{"key":"10.1016\/j.jad.2025.120335_bb0155","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jad.2025.120335_bb0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120335_bb0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41386-023-01656-7","article-title":"Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism","volume":"49","author":"Mitchell","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.120335_bb0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/bs.pbr.2018.08.004","article-title":"Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: contributions of the resting brain","volume":"242","author":"M\u00fcller","year":"2018","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.jad.2025.120335_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118143","article-title":"The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network","volume":"10","author":"Palhano-Fontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2025.120335_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2020.01681","article-title":"Psychedelic research and the need for transparency: polishing Alice\u2019s looking glass","volume":"11","author":"Petranker","year":"2020","journal-title":"Front. Psychol."},{"key":"10.1016\/j.jad.2025.120335_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063095","volume":"13","author":"Pigott","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2025.120335_bb0190","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40263-022-00944-y","article-title":"A research domain criteria (RDoC)-guided dashboard to review psilocybin target domains: a systematic review","volume":"36","author":"Pouyan","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2025.120335_bb0195","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s40263-023-01044-1","article-title":"The effects of lysergic acid diethylamide (LSD) on the positive valence systems: a research domain criteria (RDoC)-informed systematic review","volume":"37","author":"Pouyan","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2025.120335_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cegh.2023.101484","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clinical Epidemiology and Global Health"},{"key":"10.1016\/j.jad.2025.120335_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115880","article-title":"Safety and risk assessment of psychedelic psychotherapy: a meta-analysis and systematic review","volume":"335","author":"Romeo","year":"2024","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.120335_bb0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuropharm.2017.12.041","article-title":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","volume":"142","author":"Roseman","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2025.120335_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-57033-2","article-title":"Default mode network connectivity and social dysfunction in major depressive disorder","volume":"10","author":"Saris","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2025.120335_bb0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/02698811221125354","article-title":"Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression","volume":"37","author":"Shukuroglou","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.120335_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105325","article-title":"The relationship between the default mode network and the theory of mind network as revealed by psychedelics \u2013 a meta-analysis","volume":"152","author":"Soares","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.120335_bb0230","first-page":"512","article-title":"Expectancy effects in psychedelic trials","volume":"9","author":"Szigeti","year":"2024","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.jad.2025.120335_bb0235","article-title":"Transdiagnostic neuroimaging markers of psychiatric risk: a narrative review","volume":"30","author":"Vanes","year":"2021","journal-title":"NeuroImage: Clinical"},{"key":"10.1016\/j.jad.2025.120335_bb0245","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jad.2023.04.081","article-title":"Increased low-frequency brain responses to music after psilocybin therapy for depression","volume":"333","author":"Wall","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120335_bb0250","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.20230751","article-title":"Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression","author":"Wall","year":"2025","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.120335_bb0255","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jad.2024.01.142","article-title":"A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): a systematic review","volume":"350","author":"Wong","year":"2024","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.120335_bb0260","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jamapsychiatry.2015.0484","article-title":"Resting-state functional connectivity in psychiatric disorders","volume":"72","author":"Woodward","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2025.120335_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1386321","article-title":"Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review","volume":"15","author":"Yu","year":"2024","journal-title":"Front. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272501777X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272501777X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:43:55Z","timestamp":1780634635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503272501777X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":52,"alternative-id":["S016503272501777X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120335","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120335"}}